益客食品(301116) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 reached ¥5,161,637,070.11, representing a 42.76% increase compared to ¥3,615,663,110.33 in the same period last year[5] - Net profit attributable to shareholders was ¥117,018,996.47, a significant turnaround from a loss of ¥84,073,009.59, marking a 239.19% increase[5] - The net cash flow from operating activities was ¥285,381,840.91, compared to a negative cash flow of ¥245,021,681.85 in the previous year, reflecting a 216.47% improvement[5] - Basic and diluted earnings per share increased to ¥0.26 from a loss of ¥0.19, representing a 236.84% increase[5] - Total operating revenue for Q1 2023 reached CNY 5,161,637,070.11, a significant increase from CNY 3,615,663,110.33 in the same period last year, representing a growth of approximately 42.7%[25] - Net profit for Q1 2023 was 143,677,155.11 CNY, a significant recovery from a net loss of 92,657,715.44 CNY in Q1 2022[26] - Operating profit for Q1 2023 was 144,293,484.32 CNY, compared to an operating loss of 91,673,801.66 CNY in Q1 2022[26] - The company reported a total comprehensive income of 143,677,155.11 CNY for Q1 2023, compared to a total comprehensive loss of 92,657,715.44 CNY in Q1 2022[26] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥5,037,290,959.96, up 2.74% from ¥4,902,992,094.67 at the end of the previous year[5] - Total liabilities decreased slightly to CNY 2,880,465,220.99 from CNY 2,884,886,685.07, a reduction of about 0.2%[23] - The company's total equity increased to CNY 2,156,825,738.97 from CNY 2,018,105,409.60, representing a growth of approximately 6.9%[23] - Cash and cash equivalents at the end of Q1 2023 amounted to CNY 462,349,537.17, up from CNY 332,069,868.26 at the beginning of the year, indicating a growth of about 39.2%[22] - Accounts receivable increased to CNY 628,132,105.17 from CNY 543,664,540.55, reflecting a rise of approximately 15.6%[22] - Inventory decreased to CNY 1,137,271,111.28 from CNY 1,319,685,042.20, showing a decline of about 13.8%[22] - Short-term borrowings rose to CNY 1,006,873,856.70 from CNY 877,994,457.32, indicating an increase of about 14.6%[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,112[16] - Jiangsu Yike Agricultural Investment Co., Ltd. holds 314,772,806 shares, accounting for 70.11% of total shares[16] - The top ten shareholders include Central Enterprise Rural Industry Investment Fund Co., Ltd. with 18,367,347 shares (4.09%) and Qingdao Yunsheng Equity Investment Partnership with 12,711,864 shares (2.83%)[16] - The total number of shares held by the top ten unrestricted shareholders is 62,000,000[18] - The company has a total of 314,772,806 restricted shares held by Jiangsu Yike Agricultural Investment Co., Ltd., which will be released on January 18, 2025[18] - The company plans to release 18,367,347 restricted shares held by Central Enterprise Rural Industry Investment Fund on January 20, 2023[18] - The shareholder structure indicates a concentration of ownership, with the top three shareholders holding over 76% of the total shares[16] Operational Insights - The increase in revenue was driven by higher sales volumes and prices of chicken and duck products[12] - Investment income rose significantly by 444.73% to ¥320,754.72, attributed to increased returns from held financial products[12] - The company reported a 70.76% increase in prepayments, primarily due to higher advance payments for feed raw materials[10] - The net cash flow from financing activities decreased by 83.70% to ¥80,122,234.07, largely due to a significant IPO financing amount in the same period last year[13] Future Outlook - The company has not disclosed any future performance guidance or outlook in the provided documents[17] - The company plans to continue expanding its market presence and invest in new product development to sustain growth in the upcoming quarters[20] - There are no significant market expansion or acquisition strategies outlined in the reports[17] - The company has no new product or technology developments mentioned in the reports[17] Research and Development - Research and development expenses for Q1 2023 were 5,640,306.42 CNY, slightly down from 5,874,114.38 CNY in Q1 2022[26] Audit Information - The company did not undergo an audit for the Q1 2023 report[29]